Figure 1. The formation of a virus-like particle (VLP). Image Credit: Sino Biological Inc. To enable targeted drug research, Sino Biological has created a VLP protein platform based on the HEK293 ...

In the Virus-Like Particle Translational Oncology Laboratory ... In preclinical studies, VLPs formed by structural proteins are highly immunogenic and capable of inducing protective immunity against ...

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

For all the mysteries that remain about the novel coronavirus and the COVID-19 disease it causes, scientists have generated an incredible amount of fine-grained knowledge in a surprisingly short time.

The virus particle comes apart, releasing the viral genome. The viral RNA (vRNA) is translated into a single polypeptide that is cut into ten proteins ... other cells. Like other viruses, the ...

The development of vaccines against NiV is a priority, with various approaches under investigation, including virus-like particle-based and mRNA-based vaccines. However, no vaccine is yet approved ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it ...

A specialized protein produced by the immune system ... A lipid (fatty) covering that surrounds a viral particle. It is derived from the cell membrane of the host cell when the virus buds, or exits, ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

The development of vaccines against NiV is a priority, with various approaches under investigation, including virus-like particle-based and mRNA-based vaccines. However, no vaccine is yet approved ...